Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Europe News Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health & Science Novo Nordisk A/S Labor economy
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Business Pharmaceuticals Health & Science
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Eisai Co Ltd Eli Lilly and Co Mad Money
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Business Pharmaceuticals Science
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags stocks RH Stock markets
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Science Healthy Returns Health & Science
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Breaking News: Technology Eli Lilly and Co Alphabet Inc
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Technology Alphabet Inc Eli Lilly and Co
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Personal finance Personnel Novo Nordisk A/S
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags ETF Edge Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Teladoc Health Inc Goldman Sachs Group Inc Hims & Hers Health Inc
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags US: News Companies Biotechnology
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Trump Media & Technology Group Corp Markets Market Outlook
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investment strategy Biotech and Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Uber Technologies Inc
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Health care industry Eli Lilly and Co Roche Holding AG
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Healthy Returns Health care industry Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Social issues Biotechnology Companies
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Technology Microsoft Corp Alphabet Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Apple Inc Health care industry
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Health & Science Business News US: News
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Drugs AI / Artificial Intelligence Pharmaceuticals
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Tags Biotech and Pharmaceuticals Europe News Eli Lilly and Co
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Amgen Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Tags Pharmaceuticals Business Breaking news
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Super Micro Computer Inc Qualcomm Inc Eli Lilly and Co
From CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
Tags Carvana Co U/S/ Markets Stock markets
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.